Semaglutide
Semaglutide for Diabetes Control
Revolutionizing treatment for effective blood sugar management.
Semaglutide for Weight Loss
A proven solution for sustainable weight management.
Clinically Proven Semaglutide Benefits
Effective in improving glycemic control and overall metabolic health.
Innovating Healthcare
Partner with us to develop advanced Semaglutide therapies.
Semaglutide Intermediate P29
Semaglutide Intermediate P29 is a key precursor in the synthesis of semaglutide, a GLP-1 receptor agonist used in the treatment of type 2 diabetes and obesity. This intermediate plays a crucial role in the production of semaglutide by providing the necessary structural components for the peptide’s bioactivity and stability. Its chemical structure features specific modifications that enhance the synthesis process, ensuring the desired pharmacological properties are achieved in the final product.
Semaglutide Intermediate P29 is designed to facilitate efficient peptide synthesis, providing a critical building block for the development of advanced therapies that offer improved patient outcomes in glucose management and weight loss.
CAS No: 1169630-82-3
>>Download COA
Application:
- Peptide Synthesis: Essential in the production of semaglutide and related GLP-1 receptor agonists.
- Pharmaceutical Development: Used in the manufacture of diabetes and obesity treatments.
- Medicinal Chemistry: Supports the creation of modified peptides for improved therapeutic efficacy.
Storage condition: Store in a cool, dry place, away from direct sunlight. Recommended storage temperature: -20°C.
Packing: Customized
Need more information/samples?